Advertisement

Topics

[Viewpoint] Prevention of Ebola virus disease through vaccination: where we are in 2018

20:23 EDT 10 Aug 2018 | The Lancet

In 2016, Guinea, Liberia, and Sierra Leone succeeded in interrupting the longest epidemic of Ebola virus disease in global history.1 Control of the epidemic was primarily achieved by implementation of effective and coordinated public health measures that involved rapid identification, isolation of cases, contact tracing, and isolation of contacts. However, the risk of re-emergence of Ebola virus disease is real, as shown by the 2017 and 2018 outbreaks in the Democratic Republic of the Congo. Consequently, along with other public health measures, efforts to develop an effective vaccine against Ebola virus disease must continue.

Original Article: [Viewpoint] Prevention of Ebola virus disease through vaccination: where we are in 2018

NEXT ARTICLE

More From BioPortfolio on "[Viewpoint] Prevention of Ebola virus disease through vaccination: where we are in 2018"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Marburg and Ebola Virus Infections
Ebola virus and Marburg virus are related viruses that cause hemorrhagic fevers — illnesses marked by severe bleeding (hemorrhage), organ failure and, in many cases, death. Both viruses are native to Africa, where sporadic outbreaks have occurred f...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...